Skip to main content

Table 4 Comparison of protein expression between breast cancer tissues and their matched adjacent tissues

From: β2-microglobulin has a different regulatory molecular mechanism between ER+ and ER breast cancer with HER2

 

Luminal A (n = 81)

Basal-like (n = 40)

Adjacent

IHS median (range)

Breast cancer

IHS median (range)

Z

p

Adjacent

IHS median (rang)

Breast cancer

IHS median (range)

Z

p

β2M

0 (0–5.4)

5 (3–6.4)

− 2.847

0.004

2 (0–5.4)

5 (0–7)

− 2.090

0.037

HIF-1α

5.1 (4–6)

5.6 (5–6)

− 2.160

0.031

5 (0–6.2)

5.2 (3–5.8)

−1.336

0.181

p-CREB

5.33 (3.5–6.2)

6.5 (5.3–7)

− 3.434

0.001

5.7 (4–6.6)

5.95 (2.7–6.5)

−0.345

0.730

VEGF

0 (0–6)

5.8 (3–6.8)

− 3.469

0.001

2.5 (0–5.4)

5.5 (3.2–6.0)

−2.867

0.004

p-SGK1

5.1 (0–7)

5.9 (5.1–6.4)

−2.272

0.023

6 (4.3–6.5)

5.9 (5–6.2)

−0.677

0.498

p-ERK1/2

4.55 (0–6.3)

6.1 (5–6.8)

−2.858

0.004

5.2 (3–6.2)

5.64 (4.4–6.5)

−1.098

0.272

Bcl-2

0 (0–5)

3.9 (0–5.4)

−2.483

0.013

0 (0–5)

5 (0–5.4)

−3.083

0.002

  1. n The number of patients with breast cancer